ArticleNutrients2019
Immunomodulatory Effect of Gut Microbiota-Derived Bioactive Peptides on Human Immune System from Healthy Controls and Patients with Inflammatory Bowel Disease.
Open access · goldAbstract read
In one paragraph
Article in Nutrients, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 45 citations in OpenAlex.
- Daily, oral FMT for long-term maintenance therapy in ulcerative colitis: results of a single-center, prospective, randomized pilot study.BMC gastroenterology · 2021Trial
- Corisin induces proteostasis stress to drive epithelial injury and pulmonary fibrosis.Nature communications · 2026Article
- Comprehensive 16s rRNA sequencing and metabolomics to investigate the effect of anticancer bioactive peptides combined with oxaliplatin on gastric cancer.Scientific reports · 2026Article
- Dietary Nitrogen and Its Role in the Gut Microbiome and Inflammatory Bowel Disease: A Narrative Review.Nutrients · 2025Review
- Anti-Inflammatory Peptides as Promising Therapeutics Agent Against Inflammatory Bowel Diseases: A Systematic Review.JGH open : an open access journal of gastroenterology and hepatology · 2025Review
- Article
- Gut bacteria: an etiological agent in human pathological conditions.Frontiers in cellular and infection microbiology · 2024Review
- Examining the functional space of gut microbiome-derived peptides.MicrobiologyOpen · 2023Article
- Microbiome Alterations and Alzheimer's Disease: Modeling Strategies with Transgenic Mice.Biomedicines · 2023Review
- GAPDH Released fromMicroorganisms · 2023Article
- Bacterial Lysate from the Multi-Strain Probiotic SLAB51 Triggers Adaptative Responses to Hypoxia in Human Caco-2 Intestinal Epithelial Cells under Normoxic Conditions and Attenuates LPS-Induced Inflammatory Response.International journal of molecular sciences · 2023Article
- Serum metabolic effects of corn oligopeptides with 7-day supplementation on early post-surgery primary liver cancer patients: a double-blind randomized controlled trial.Hepatobiliary surgery and nutrition · 2022Article
- Transepithelial transport and cellular mechanisms of food-derived antioxidant peptides.Heliyon · 2022Review
- Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis.International journal of molecular sciences · 2022Article
- Paraprobiotics and Postbiotics ofMicroorganisms · 2022Article
- Role of microbial secreted proteins in gut microbiota-host interactions.Frontiers in cellular and infection microbiology · 2022Review
- Gut Microbiota and Dietary Factors as Modulators of the Mucus Layer in Inflammatory Bowel Disease.International journal of molecular sciences · 2021Review
- Looking into key bacterial proteins involved in gut dysbiosis.World journal of methodology · 2021Review
- The Modification of the Gut Microbiota via Selected Specific Diets in Patients with Crohn's Disease.Nutrients · 2021Review
- Gut Microbiome of a Multiethnic Community Possessed No Predominant Microbiota.Microorganisms · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 3 institutions in 1 country.
Samuel Fernández-ToméHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, 28006 Madrid, Spain. fernandeztome.samuel@gmail.com.
Alicia C MarinHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, 28006 Madrid, Spain. aliciacmarin@gmail.com.
Lorena Ortega MorenoHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, 28006 Madrid, Spain. lorena.ortega8317@gmail.com.
Montserrat Baldan-MartinHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, 28006 Madrid, Spain. mbaldanm@gmail.com.
Irene Mora-GutiérrezHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, 28006 Madrid, Spain. irelab158@gmail.com.
Aitor Lanas-GimenoHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, 28006 Madrid, Spain. aitor.lanas.gimeno@gmail.com.
José Andrés Moreno-MonteagudoHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, 28006 Madrid, Spain. jamorenomonteagudo@hotmail.com.
Cecilio SantanderHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, 28006 Madrid, Spain. cecilio.santander@salud.madrid.org.
Borja SánchezInstituto de Productos Lácteos de Asturias (IPLA-CSIC), 33300 Asturias, Spain. borja.sanchez@csic.es.
María ChaparroHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, 28006 Madrid, Spain. mariachs2005@gmail.com.
Javier P GisbertHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, 28006 Madrid, Spain. javier.p.gisbert@gmail.com.
David BernardoHospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, 28006 Madrid, Spain. d.bernardo.ordiz@gmail.com.ORCID 0000-0002-2843-6696
Hospital Universitario de La Princesa · ESInstituto de Productos Lácteos de Asturias · ESUniversidad de Valladolid · ES
Funding
Community of Madrid Consejería de Educación, Juventud y Deporte, Programa de Garantía Juvenil 2015 and 2016Grupo Español de Trabajo en Enfermedad Crohn y Colitis Ulcerosa GETECCUInstituto de Salud Carlos III Sara Borrell fellowship CD17/00014Spanish Ministry of Economy RYC-2017-21606Spanish Ministry of Economy SAF2014-56642-JINSpanish Ministry of Health PIE13/00041
Abstract
Bioactive peptides secreted by probiotic
Indexed as
Antigen-Presenting CellsCytokinesGastrointestinal MicrobiomeInflammatory Bowel DiseasesBacterial ProteinsBiological ProductsCells, CulturedHumansImmunomodulationIntestinal MucosaPeptidesBacterial ProteinsBiological ProductsCytokinesPeptidesantigen presenting cellsbioactive peptideshumanIBDimmunomodulationmicrobiota
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.